Psoriasis type and body distribution
Plaque, guttate, inverse, scalp, nail, palmoplantar or other patterns are described with body areas involved.
← Specialist review & coordination areas
Dermatology evaluation
Psoriasis Specialist Review & Care Coordination
A dermatology-oriented review for psoriasis, structured around disease pattern, severity, lesion photos, joint symptoms, previous therapy, comorbidities and whether a Cuba-related topical treatment discussion is appropriate.
Medical disclaimer: This page is for information and international coordination only. It does not diagnose, prescribe, guarantee suitability or replace urgent local medical care.
Clinical file logic
01
02
03
04
05
06
The evaluation is based on severity, pattern and safety context.
Psoriasis review should not be reduced to a skin photo. Disease extent, flare pattern, scalp/nail/genital involvement, joint pain, previous systemic therapy and comorbidities can all change the next step. The file is organized so the patient receives a careful written review rather than a generic generic suggestion.
Severity and quality-of-life impact
Extent, itching, pain, bleeding, fissures, sleep impact and daily function are documented.
Joint and nail symptoms
Joint pain, swelling, morning stiffness and nail changes are important because psoriatic arthritis may require different care.
Previous treatment history
Topicals, phototherapy, systemic agents, biologics or alternative options are listed with response and side effects.
Comorbidities and contraindications
Liver disease, kidney disease, infection risk, pregnancy, obesity, diabetes and medications are reviewed.
Specialist question
The file should clarify whether the request is for second opinion, treatment context, supportive topical care or broader dermatology planning.
Review framework
What changes the next step.
The page is intentionally structured around clinical decision factors, not around promotional claims. The aim is to make the file safer, clearer and easier to review.
Psoriasis can be systemic
Joint symptoms or extensive disease may need local specialist care and cannot be managed as a cosmetic issue.
Topical context has limits
Cuba-related topical discussions, including Coriodermina® context, must be physician-reviewed and not presented as a universal treatment.
Severity changes the route
Mild localized plaques and severe widespread disease require different expectations, safety checks and follow-up planning.
Photos need context
Close and distant photos help, but without prior therapy and symptom history they may not explain the clinical problem.
Documents to prepare
A complete file creates a better written response.
A psoriasis file should show not only lesions, but also severity, previous therapy and systemic risk. These items help avoid superficial review.
Clinical photosClear photos of representative plaques, scalp, nails or affected areas.
Disease historyStart date, flare pattern, triggers, body areas and quality-of-life impact.
Previous treatmentsTopical, phototherapy, systemic or biologic therapies, dates and response.
Joint symptomsPain, swelling, stiffness, rheumatology notes or imaging if available.
Medical backgroundLiver/kidney disease, infections, pregnancy status, diabetes and medications.
Dermatology notesDiagnosis confirmation, PASI/BSA/DLQI if documented and biopsy if performed.
Cuba context
How the treatment discussion is framed responsibly.
The page does not present a procedure or travel plan as automatically suitable. Any Cuba-related discussion remains conditional on physician review of the current file.
Local medical care remains the baseline
The patient should continue appropriate local care while the file is being organized, especially when symptoms are active or worsening.
Named options are not presented as guarantees
Treatment names may be part of the medical context, but suitability, contraindications, dosing and monitoring must be determined by physicians.
Travel is not the first decision
The first decision is whether the file is complete enough for a responsible written response. Logistics come only after clinical clarity.
Options discussed in Cuba
Coriodermina and the treatment ladder in psoriasis
Psoriasis is a chronic condition that can be controlled but not eradicated.
Coriodermina, developed in Cuba by Dr Carlos Miyares Cao, is a water-soluble gel derived from human placenta. The reported mechanism is regulation of epidermal cell turnover and reduction of the effect of cytokines and neuropeptides involved in inflammation and itch. It is applied directly to psoriatic lesions, usually in planned courses.
International peer-reviewed evidence for this product is limited. The best-defined steps in psoriasis today are topical corticosteroids and vitamin D analogues in mild disease; phototherapy, systemic agents (methotrexate, acitretin) in moderate to severe disease; and biologic agents in selected patients. Biologics are high-evidence options that can produce marked improvement in moderate to severe plaque psoriasis.
Psoriasis is not only a skin disease. Assessment for joint involvement (psoriatic arthritis), metabolic syndrome, cardiovascular risk and depression belongs in the treatment plan. Where there is joint pain and morning stiffness, rheumatology assessment takes priority, because untreated joint disease can cause permanent damage.
Severity measurement
Body surface area involved and PASI-type scoring determine which step of the ladder applies; photographs support this.
Joint involvement
Joint pain, swelling and morning stiffness should be asked about; if present, rheumatology assessment changes the plan.
Triggers
Infection, stress, smoking, certain drugs and trauma can trigger flares; noting them in the file improves the plan.
When local care comes first
Do not wait for international review if urgent symptoms are present.
International coordination should never delay emergency or necessary local care. If any of the following are present, the patient should be assessed locally first.
- Severe widespread flare with fever, dehydration, skin pain or suspected erythroderma.
- Signs of skin infection, rapidly worsening lesions, pus, severe swelling or uncontrolled pain.
- New severe joint swelling, eye symptoms or systemic illness requiring local assessment.
Coordination pathway
From records to written next steps.
- File intakeReports, photos, laboratory results and current symptoms are uploaded through the application flow.
- Quality checkThe coordination team checks readability, dates, translation needs and missing items before routing the case.
- Specialist routingThe case is prepared around a clear medical question and sent through the relevant review pathway.
- Written responseThe patient receives organized next steps before travel, payment or treatment logistics are considered.
Questions
Before starting the application.
Does this page replace my dermatologist?
No. It prepares the file for coordination and review. Diagnosis, treatment and follow-up remain physician-led.
Can psoriasis be reviewed from photos only?
Photos help but are not enough. Severity, prior therapy, joint symptoms and comorbidities are important.
Is Coriodermina® automatically appropriate?
No. Any topical treatment context must be reviewed according to diagnosis, severity, skin condition and physician advice.
What if I have joint pain?
Joint pain or stiffness should be documented and may require local rheumatology/dermatology care before international coordination.
Can I travel immediately for psoriasis care?
Travel should not be planned before the file is reviewed and written next steps are clear.
Related evaluation pages
Other specialty files reviewed through the same clinical coordination approach.
Official product information
Coriodermina: the only registered presentation, and a counterfeit warning
The data below are taken from the product summary approved by CECMED, the Cuban medicines regulator. They describe the product as licensed in Cuba and are not a treatment recommendation.
- Registration
- Sanitary registration 1383, first registered April 1998. Placenta extract (EP 100), 45.0 g per 100 g.
- Manufacturer
- Planta de Derivados de la Placenta (Centre of Placental Histotherapy), Cuba
- The only registered form
- In Cuba the only presentation holding a CECMED registration is CORIODERMINA jelly in a 250 g jar. It is sold only in Cuba and is dispensed at the clinic of the Centre of Placental Histotherapy.
- Approved indication
- Psoriasis. Vitiligo and acne are not approved indications for this product.
- Official counterfeit warning
- In Risk Communication 04/2015 the Cuban regulator CECMED reported websites selling "Coriodermina" as tablets, jelly, soap, shampoo, dietary supplement powder and "Coriodermina Plus Vitiligo" lotions, using the logo of the Centre of Placental Histotherapy. CECMED classified these as fraudulent medicines whose quality, safety and efficacy are not guaranteed and which represent a public health risk.
- What this means for you
- If you are offered Coriodermina in any form other than the 250 g jelly, or through a website, treat it as counterfeit. Ask your coordination team to verify the source before any payment.
Approval in Cuba does not mean approval in your country, and it does not mean the product is suitable for you. Eligibility is decided by the physician who reviews your complete file.
Start with the file
Submit documents before making a travel or treatment decision.
A coordinator will organize the medical information and guide the next step according to specialist review. The process is designed to be transparent, clinically cautious and written.